Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 23, 2024

BUY
$437.42 - $470.64 $226,583 - $243,791
518 New
518 $240,000
Q2 2023

Aug 15, 2023

BUY
$354.01 - $427.31 $1.57 Million - $1.9 Million
4,440 Added 230.53%
6,366 $2.72 Million
Q4 2022

Mar 24, 2023

BUY
$346.68 - $397.58 $659,732 - $756,594
1,903 Added 8273.91%
1,926 $722,000
Q3 2022

Nov 15, 2022

BUY
$321.25 - $373.84 $7,388 - $8,598
23 New
23 $8,000
Q2 2022

Aug 16, 2022

SELL
$300.57 - $336.42 $96,783 - $108,327
-322 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$244.61 - $310.48 $78,764 - $99,974
322 New
322 $98,000
Q4 2021

Feb 15, 2022

SELL
$198.21 - $248.9 $196,624 - $246,908
-992 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$188.42 - $208.66 $5,275 - $5,842
28 Added 2.9%
992 $152,000
Q2 2021

Aug 16, 2021

BUY
$184.89 - $202.68 $178,233 - $195,383
964 New
964 $184,000
Q3 2020

Nov 17, 2020

SELL
$140.89 - $159.9 $1.51 Million - $1.71 Million
-10,718 Closed
0 $0
Q2 2020

Aug 17, 2020

BUY
$125.49 - $164.68 $1.22 Million - $1.6 Million
9,726 Added 980.44%
10,718 $1.64 Million
Q2 2020

Aug 17, 2020

BUY
$125.49 - $164.68 $124,486 - $163,362
992 New
992 $152,000
Q1 2020

May 15, 2020

SELL
$115.75 - $170.96 $109,383 - $161,557
-945 Closed
0 $0
Q4 2019

Feb 13, 2020

SELL
$130.23 - $153.27 $481,330 - $566,485
-3,696 Reduced 79.64%
945 $131,000
Q3 2019

Nov 21, 2019

SELL
$134.24 - $148.53 $815,776 - $902,616
-6,077 Reduced 56.7%
4,641 $642,000
Q2 2019

Aug 15, 2019

SELL
$112.47 - $134.93 $179,277 - $215,078
-1,594 Reduced 12.95%
10,718 $1.44 Million
Q1 2019

May 15, 2019

BUY
$111.86 - $136.3 $1.16 Million - $1.42 Million
10,399 Added 543.6%
12,312 $1.44 Million
Q4 2018

Feb 14, 2019

BUY
$108.23 - $136.84 $207,043 - $261,774
1,913 New
1,913 $211,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $71B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Neo Ivy Capital Management Portfolio

Follow Neo Ivy Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neo Ivy Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Neo Ivy Capital Management with notifications on news.